Temephos

Agent Name
Temephos
Alternative Name
Abate
CAS Number
3383-96-8
Formula
C16-H20-O6-P2-S3
Major Category
Pesticides
Temephos formula graphical representation
Synonyms
Abate; AC 52160; Abaphos; Abate; Abate 4-E; Abathion; American cyanamid AC 52,160; American cyanamid CL-52160; American cyanamid E.I. 52,160; Biothion; Bis-p-(O,O-dimethyl O-phenylphosphorothioate)sulfide; Bithion; CL 52160; Difenphos; Difos; Diphos; Diphos (pesticide); EI 52160; Ecopro 1707; Etidronsaeure; Experimental insecticide 52160; Lypor; Nephis; Nephis 1G; Nimitex; Nimitox; O,O'-(Thiodi-4,1-phenylene) O,O,O',O'-tetramethyl di(phosphorothioate); O,O'-(Thiodi-4,1-phenylene)bis(O,O-dimethyl phosphorothioate); O,O'-(Thiodi-4,1-phenylene)phosphorothioic acid O,O,O',O'-tetramethyl ester; O,O'-(Thiodi-p-phenylene) O,O,O',O'-tetramethyl bis(phosphorothioate); O,O'-(Thiodi-p-phenylene) O,O,O',O'-tetramethyl di(phosphorothioate); O,O,O',O'-Tetramethyl O,O'-thiodi-P-phenylene bis(phosphorothioate); O,O,O',O'-Tetramethyl O,O'-thiodi-p-phenylene diphosphorothioate; O,O-Dimethyl phosphorothioate O,O-diester with 4,4'-thiodiphenol; OMS 786; Phenol, 4,4'-thiodi-, O,O-diester with O,O-dimethyl phosphorothioate; Phosphorothioic acid, O,O'-(thiodi-p-phenylene) O,O,O',O'-tetramethyl ester (8CI); Procida; Swebat; Swebate; Temefos; Temefosum [INN-Latin]; Tetrafenphos; Tetramethyl O,O'-thiodi-p-phenylene phosphorothioate; [ChemIDplus]
Category
Organophosphate Insecticides
Description
White, crystalline solid or liquid (above 87 degrees F). [insecticide] [Note: Technical grade is a viscous, brown liquid.]; [NIOSH]
Sources/Uses
Used to kill mosquito, midge, and black fly larvae in lakes, ponds, and wetlands; also used to kill fleas and human lice; [EXTOXNET]
Comments
Classified as "slightly toxic" with an LD50 of 5 gm/kg for the 2% powder formulation; [EXTOXNET] “The average of two baseline respective cholinesterase activity determinations three days apart, with no exposures to enzyme inhibiting pesticides for at least 30 days, is recommended for each worker prior to exposure to cholinesterase inhibitors because of large inter-individual differences in published baseline values. To be established at least once a year. Removal from workplace exposures is recommended until the cholinesterase activity returns to within 20% of baseline.” [TLVs and BEIs]
Reference Link #1
Biomedical References

Exposure Assessment

BEI
Acetylcholinesterase activity in red blood cells = 70% of individual's baseline; Butylcholinesterase activity in serum or plasma = 60% of individual's baseline; Sample at end of shift; [TLVs and BEIs]
Skin Designation (ACGIH)
Yes
TLV (ACGIH)
1 mg/m3, inhalable particulate matter
PEL (OSHA)
15 mg/m3(total dust), 5 mg/m3(respirable fraction)
Vapor Pressure
7E-08 mm Hg
Reference Link #2

Adverse Effects

ACGIH Carcinogen
Not Classifiable
Other Poison
Organophosphate

Diseases, Processes, and Activities Linked to This Agent

Diseases

Occupational diseases associated with exposure to this agent:

Processes

Industrial Processes with risk of exposure: